Evaluation of antibiotic prescribing patterns and post treatment follow-up in patients with urinary tract infections: A Comprehensive analysis of clinical practices and outcomes

Main Article Content

Asma Mastur Hammad Rehim
Juny Sebastian

Keywords

Urinary Tract Infection, United Arab Emirates, recurrence, Pyelonephritis, cystitis, UTI guidelines

Abstract

Introduction: Urinary tract infections (UTIs) are a leading cause of Emergency Department (ED) visits and hospitalizations worldwide, with the Middle East showing a rising incidence. However, limited data exists on the prevalence and antibiotic prescribing patterns for UTIs in this region. Women, particularly in the 16–35 years age group, are at an increased risk of UTI. The study explores empiric antibiotic therapy for UTIs based on national recommendations, the recurrence rates, and factors influencing relapse and reinfection. Objective: This study aims to evaluate empiric antibiotic prescribing patterns for UTIs in a tertiary hospital, assess the outcomes of treatment, and analyze factors related to relapse and recurrence of UTIs. Methodology: A retrospective review of medical records was conducted for patients aged 18 years or older diagnosed with a UTI at a tertiary care hospital in the Northern Emirates, UAE. Data were collected from the Internal Medicine, Urology, and Obstetrics & Gynecology departments between January 2022 and December 2023. A structured data collection form captured demographic, clinical, microbiological, and pharmacotherapeutic details. Antibiotic treatments and patient outcomes were analyzed using SPSS software, with chi-square tests and multiple regression analyses conducted to assess risk factors for relapse and recurrence. Results: Out of 273 reviewed records, 198 patients were included, with 59.6% being female. The most common bacterial pathogen identified was Escherichia coli (33.3%). Carbapenems were the most prescribed antibiotics, used in 56% of cases, followed by ceftriaxone (14.8%). The average treatment duration was 8.5 days, with 25.3% achieving a complete cure during hospitalization. Complications such as febrile UTI were noted in 37.9% of patients, with 11.6% experiencing prolonged symptoms. Factors significantly associated with relapse included a history of anatomical defects (p = 0.006). Regression analysis showed that the type and duration of antibiotics significantly affected UTI recurrence (p < 0.001). Conclusion: The study highlights the pattern of antibiotic use in the treatment of UTIs. The recurrence of UTIs was significantly influenced by anatomical defects, underscoring the need for targeted therapeutic strategies. A tailored approach to antibiotic therapy, aligned with local resistance patterns, is essential for optimizing treatment outcomes and preventing recurrent infections.

Abstract 148 | PDF Downloads 67

References

1. Sussman M. In: Hausler WJ Jr, Sussman M editors. Topley and Wilson’s Microbiology and Microbial Infections. 9th Edition. London: Arnold; 1998: 601-21.
2. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis. 2001;183 Suppl 1:S1-4.
3. Alanazi MQ, Al-Jeraisy MI, Salam M. Prevalence and predictors of antibiotic prescription errors in an emergency department, Central Saudi Arabia. Drug Healthc Patient Saf. 2015;7:103–111
4. WHO. The World Health Report 2007. A Safer Future: Global Public Health Security in the 21st Century. World Health Organization; 2007.
5. Dielubanza EJ, Schaeffer AJ. Urinary tract infections in women. Med Clin North Am. 2011;95:27–41. https:// doi. org/ 10. 1016/j. mcna. 2010. 08. 023 (PMID: 21095409).
6. CDC. Antibiotic prescribing and use in doctor’s office. CDC, 2017. Available from: https://www.cdc.gov/antibiotic-use/community/ index.html. Accessed July 23, 2020.
7. Alkhawaldeh R, Abu Farha R, Abu Hammour K, Alefishat E. The Appropriateness of Empiric Treatment of Urinary Tract Infections in a Tertiary Teaching Hospital in Joran: A Cross-Sectional Study. Antibiotics (Basel). 2022;11(5):629. Published 2022 May 6. doi:10.3390/antibiotics11050629
8. Khatun, S. A., & Shaha. Prescribing Pattern of Antimicrobials in Urinary Tract Infection at Outpatient Department in a Tertiary Care Hospital in Dhaka. Journal of Enam Medical College. 2020;10(1):23–26. https://doi.org/10.3329/jemc.v10i1.45062
9. Chávez-Reyes J., Escárcega-González C.E., Chavira-Suárez E., León-Buitimea A., Vázquez-León P., Morones-Ramírez J.R., Villalón C.M., Quintanar-Stephano A., Marichal-Cancino B.A. Susceptibility for Some Infectious Diseases in Patients with Diabetes: The Key Role of Glycemia. Front. Public Health. 2021;9:559595. doi: 10.3389/fpubh.2021.559595.
10. Nitzan O., Elias M., Chazan B., Saliba W. Urinary tract infections in patients with type 2 diabetes mellitus: Review of prevalence, diagnosis, and management. Diabetes Metab. Syndr. Obes. Targets Ther. 2015;8:129–136. doi: 10.2147/dmso.s51792.
11. Al-Rubeaan K.A., Moharram O., Al-Naqeb D., Hassan A., Rafiullah M.R. Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes. World J. Urol. 2013;31:573–578. doi: 10.1007/s00345-012-0934-x.
12. Al-Asmary S.M., Al-Helali N.S., Abdel-Fattah M.M., Al-Jabban T.M., Al-Bamri A.M. Nosocomial urinary tract infection. Risk factors, rates and trends. Saudi Med. J. 2004;25:895–900.
13. Zhang HL, Perez R, Krishnan J, Lautenbach E, Anderson DJ. Risk Factors for Recurrence of Community-Onset Urinary Tract Infections Caused by Extended-Spectrum Cephalosporin-Resistant Enterobacterales. Open Forum Infect Dis. 2023;10(12):ofad561. Published 2023 Nov 8. doi:10.1093/ofid/ofad561
14. Durkin MJ, Keller M, Butler AM, et al. An Assessment of Inappropriate Antibiotic Use and Guideline Adherence for Uncomplicated Urinary Tract Infections. Open Forum Infect Dis. 2018;5(9):ofy198. Published 2018 Aug 10. doi:10.1093/ofid/ofy198
15. Ziolkowski G , Pawlowska I , Stasiowski M , Jachowicz E , Wojkowska-Mach J , Bi- elecki T . Multidrug-resistant micro-organisms associated with urinary tract in- fections in orthopedic patients: a retrospective laboratory-based study. Antibi- otics (Basel) 2020;10:7 .
16. Sievers J, SOAR Study Group. Antibacterial resistance among Streptococcus pneumoniae from 8 countries in Africa and the Middle East: results from the Survey of Antibiotic Resistance (SOAR) 2004-2006. Abstract C2-0425. In: Abstracts of the forty-sixth interscience conference on antimicrobial agents and chemotherapy, San Francisco, CA; Washington, DC: American Society for Microbiology; 2006.
17. Jamsheer A, Rafay AM, Daoud Z, Morrissey I, Torumkuney D. Results from the survey of antibiotic resistance (SOAR) 2011-13 in the Gulf States. J Antimicrob Chemother. 2016;71(Suppl 1):i45–61. https://doi.org/10.1093/jac/dkw064
18. Alghoraibi H, Asidan A, Aljawaied R, et al. Recurrent Urinary Tract Infection in Adult Patients, Risk Factors, and Efficacy of Low Dose Prophylactic Antibiotics Therapy. J Epidemiol Glob Health. 2023;13(2):200-211. doi:10.1007/s44197-023-00105-4